Close Menu
  • DRUGS
  • DISEASES
  • Treatments
  • Wellness

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Squamous Cell Carcinoma

Cancer

Chondrosarcom

Cancer

Angiosarcoma

Cancer
Facebook X (Twitter)
GoodMedTodayGoodMedToday
  • Demos
  • Health
  • Covid19
  • About Us
Facebook X (Twitter)
SUBSCRIBE
  • DRUGS
  • DISEASES
  • Treatments
  • Wellness
GoodMedTodayGoodMedToday
Home - A - Acebutolol
A

Acebutolol

Facebook Twitter Pinterest LinkedIn Tumblr Reddit WhatsApp Email
Share
Facebook Twitter LinkedIn Pinterest WhatsApp Email

Comprehensive Guide to Acebutolol: Uses, Dosage, Side Effects, and More

Table of Contents

Toggle
  • What is Acebutolol?
  • Overview of Acebutolol
  • Indications and Uses of Acebutolol
  • Dosage of Acebutolol
  • How to Use Acebutolol
  • Contraindications for Acebutolol
  • Warnings & Precautions for Acebutolol
  • Overdose and Management of Acebutolol
  • Side Effects of Acebutolol
  • Drug Interactions with Acebutolol
  • Patient Education or Lifestyle
  • Pharmacokinetics of Acebutolol
  • Pharmacodynamics of Acebutolol
  • Storage of Acebutolol
  • Frequently Asked Questions (FAQs)
  • Regulatory Information
  • References

What is Acebutolol?

Acebutolol is a beta-blocker medication used primarily to treat hypertension (high blood pressure) and cardiac arrhythmias, such as ventricular arrhythmias. As a selective beta-1 adrenergic receptor blocker with intrinsic sympathomimetic activity (ISA), this drug reduces heart rate and blood pressure while maintaining some baseline cardiac stimulation. Marketed under brand names like Sectral, the treatment is administered orally and is valued for its efficacy in managing cardiovascular conditions with a lower risk of bronchospasm compared to non-selective beta-blockers. The medication’s benefits include blood pressure control and arrhythmia prevention, but it requires monitoring for potential side effects like bradycardia or fatigue.

Overview of Acebutolol

Generic Name: Acebutolol

Brand Name: Sectral, generics

Drug Group: Beta-1 selective adrenergic receptor blocker; antiarrhythmic; antihypertensive

Commonly Used For

  • Treat hypertension in adults, alone or in combination with other antihypertensives.
  • Manage ventricular arrhythmias, including premature ventricular contractions (PVCs).
  • Off-label uses include angina pectoris, anxiety-related tachycardia, or post-myocardial infarction management under specialist guidance.

Key Characteristics

Form: Oral capsules (200 mg, 400 mg); oral tablets in some markets.

Mechanism: Selectively blocks beta-1 receptors, reducing cardiac output and heart rate; ISA minimizes excessive heart rate reduction.

A white prescription bottle of Acebutolol Hydrochloride Capsules, USP 400 mg by Amneal Pharmaceuticals, containing 100 capsules, used for treating high blood pressure and angina.
Acebutolol Hydrochloride 400 mg capsules, manufactured by Amneal Pharmaceuticals, are a beta-blocker medication commonly prescribed for the management of hypertension (high blood pressure) and angina pectoris.

Approval: FDA-approved (1984 for Sectral) and EMA-approved for hypertension and arrhythmias.

Indications and Uses of Acebutolol

Acebutolol is indicated for:

Hypertension: Lowers blood pressure in adults to reduce the risk of cardiovascular events like stroke or heart attack.

Ventricular Arrhythmias: Controls irregular heart rhythms, such as PVCs, to stabilize cardiac function.

Off-Label Uses: May be used for stable angina, performance anxiety (e.g., tachycardia), or secondary prevention post-myocardial infarction under specialist supervision.

Note: The medication is not a cure for hypertension or arrhythmias and is often used as part of a comprehensive treatment plan, including lifestyle modifications.

Dosage of Acebutolol

Important Note: Acebutolol dosage must be prescribed by a healthcare provider. Dosing is individualized based on condition, response, and renal function.

Dosage for Adults

Hypertension:

  • Initial: 400 mg orally once daily or 200 mg twice daily.
  • Maintenance: 400–800 mg/day, adjusted based on blood pressure response.
  • Maximum: 1,200 mg/day (rarely used).

Ventricular Arrhythmias:

  • Initial: 200 mg orally twice daily.
  • Maintenance: 600–1,200 mg/day, divided into two doses.

Off-Label (e.g., Angina): 200–600 mg/day, titrated by a specialist.

Dosage for Children

Not approved for pediatric use; limited data exist for off-label use in adolescents under specialist oversight.

Dosage for Pregnant Women

Pregnancy Category B: Limited human data; use only if benefits outweigh risks, as beta-blockers may cause fetal bradycardia. Consult a cardiologist.

Dosage Adjustments

Renal Impairment:

  • CrCl 25–49 mL/min: Reduce dose by 50%.
  • CrCl <25 mL/min: Reduce dose by 75% or avoid.

Hepatic Impairment: No specific adjustments; monitor for prolonged effects.

Elderly: Start with lower doses (e.g., 200 mg/day) due to reduced renal function.

Additional Considerations

  • Take with or without food; food may delay absorption but does not affect efficacy.
  • Monitor blood pressure and heart rate regularly during dose titration.

How to Use Acebutolol

Administration: Take the medication orally as capsules or tablets, with or without food. Swallow whole with water.

Timing: Administer once or twice daily as prescribed; consistency aids blood pressure and rhythm control.

Missed Dose: Take as soon as remembered unless it’s nearly time for the next dose; do not double doses. Consult your doctor if multiple doses are missed.

Additional Tips:

  • Do not abruptly stop the drug, as this may cause rebound hypertension or arrhythmias; taper under medical supervision.
  • Report symptoms like dizziness, fatigue, or slow heart rate immediately.

Contraindications for Acebutolol

Patients with hypersensitivity to Acebutolol or other beta-blockers.

Those with severe bradycardia, second- or third-degree heart block, or sick sinus syndrome (unless a pacemaker is in place).

Patients with cardiogenic shock or decompensated heart failure.

Those with severe chronic obstructive pulmonary disease (COPD) or asthma (relative contraindication due to beta-1 selectivity).

Warnings & Precautions for Acebutolol

General Warnings

Bradycardia and Hypotension: Risk of slow heart rate or low blood pressure; monitor heart rate and blood pressure regularly.

Heart Failure: May worsen heart failure in decompensated patients; use cautiously with close monitoring.

Bronchospasm: Though beta-1 selective, the medication may cause bronchospasm in susceptible patients; avoid in severe asthma.

Abrupt Discontinuation: Stopping the treatment suddenly may lead to rebound hypertension, angina, or arrhythmias; taper gradually.

Diabetes: May mask hypoglycemia symptoms (e.g., tachycardia); monitor blood glucose closely.

Use in Specific Populations

Pregnancy: Category B; use cautiously, as beta-blockers may cause fetal growth restriction or bradycardia.

Breastfeeding: Excreted in breast milk; avoid breastfeeding or monitor infant for bradycardia.

Elderly: Increased risk of bradycardia and hypotension; start with lower doses.

Children: Not approved; safety data are limited.

Renal Impairment: Adjust doses to prevent accumulation of active metabolites.

Additional Precautions

  • Inform your doctor about heart, lung, or diabetes conditions before starting the treatment.
  • Avoid activities requiring alertness (e.g., driving) if experiencing dizziness or fatigue.

Overdose and Management of Acebutolol

Overdose Symptoms

  • Severe bradycardia or heart block.
  • Hypotension or shock.
  • Bronchospasm or respiratory distress.
  • Fatigue, confusion, or seizures.

Immediate Actions

Contact Healthcare Provider: Seek medical advice immediately.

Supportive Care: Administer atropine for bradycardia, fluids for hypotension, or bronchodilators for bronchospasm.

Monitor: Check ECG, blood pressure, and respiratory status.

Additional Notes

  • Overdose risk is low with proper dosing; store securely to prevent misuse.
  • Report persistent symptoms promptly.

Side Effects of Acebutolol

Common Side Effects

  • Fatigue (10–20%)
  • Dizziness (6–14%)
  • Headache (4–10%)
  • Nausea (2–4%)
  • Bradycardia (2–5%)

These effects are often mild and may resolve with continued use.

Serious Side Effects

Seek immediate medical attention for:

Cardiac: Severe bradycardia, heart block, or worsening heart failure.

Respiratory: Bronchospasm or shortness of breath.

Allergic Reactions: Rare; rash, hives, or anaphylaxis.

Neurologic: Confusion, depression, or hallucinations (rare).

Additional Notes

  • Regular monitoring of heart rate and blood pressure is essential.
  • Report any new or worsening symptoms, especially breathing difficulties.

Drug Interactions with Acebutolol

The medication may interact with:

Other Antihypertensives (e.g., Amlodipine, Clonidine): Enhance hypotensive effects; monitor blood pressure closely.

Antiarrhythmics (e.g., Amiodarone): Increase risk of bradycardia or heart block; use with caution.

NSAIDs (e.g., Ibuprofen): Reduce antihypertensive effect; monitor blood pressure.

Sympathomimetics (e.g., Albuterol): May counteract beta-blockade; adjust doses as needed.

Insulin or Oral Hypoglycemics: Mask hypoglycemia symptoms; monitor glucose levels.

Action: Provide your healthcare provider with a complete list of medications and supplements.

Patient Education or Lifestyle

Medication Adherence: Take Acebutolol consistently as prescribed to maintain blood pressure and rhythm control. Refill prescriptions early to avoid interruptions.

Monitoring: Check blood pressure and pulse regularly at home; report readings below 50 bpm or above 100 bpm.

Lifestyle: Follow a heart-healthy diet (low sodium, low fat), exercise moderately, and avoid smoking to enhance treatment efficacy.

Avoid Abrupt Stopping: Taper the drug gradually under medical supervision to prevent rebound effects.

Diabetes Management: Monitor blood sugar closely, as the medication may mask low blood sugar symptoms.

Emergency Awareness: Carry information about your condition (e.g., hypertension) and medications for emergencies.

Pharmacokinetics of Acebutolol

Absorption: Well-absorbed orally (~40–60%); peak plasma concentration at 2–4 hours.

Distribution: Volume of distribution ~3 L/kg; moderate protein binding (26%).

Metabolism: Hepatic, via cytochrome P450; active metabolite (diacetolol) has similar beta-blocking activity.

Excretion: Renal (30–40% as diacetolol); fecal (50–60%); reduced in renal impairment.

Half-Life: Acebutolol: 3–4 hours; diacetolol: 8–12 hours.

Pharmacodynamics of Acebutolol

The drug exerts its effects by:

  • Selectively blocking beta-1 adrenergic receptors, reducing heart rate and cardiac output.
  • Lowering blood pressure by decreasing peripheral vascular resistance.
  • Stabilizing ventricular arrhythmias by reducing myocardial excitability.
  • Providing ISA, which maintains baseline cardiac stimulation, reducing severe bradycardia risk.

Storage of Acebutolol

Temperature: Store at room temperature (20–25°C or 68–77°F); avoid moisture and heat.

Protection: Keep in original container to protect from light.

Safety: Store out of reach of children to prevent accidental ingestion.

Disposal: Follow local regulations or consult a pharmacist for safe disposal of unused or expired medication.

Frequently Asked Questions (FAQs)

Q: What does Acebutolol treat?
A: The drug treats hypertension and ventricular arrhythmias.

Q: Can Acebutolol be stopped suddenly?
A: No, abrupt discontinuation may cause rebound hypertension or arrhythmias; taper under medical supervision.

Q: Is Acebutolol safe for asthma patients?
A: Use cautiously in mild asthma due to beta-1 selectivity; avoid in severe asthma or COPD.

Q: How long does Acebutolol take to work?
A: Blood pressure reduction may occur within hours, with full effects in 1–2 weeks.

Q: Can Acebutolol cause fatigue?
A: Yes, fatigue is a common side effect; report persistent symptoms to your doctor.

Regulatory Information

The medication is approved by:

U.S. Food and Drug Administration (FDA): Approved in 1984 (Sectral) for hypertension and ventricular arrhythmias.

European Medicines Agency (EMA): Approved for similar indications.

Other Agencies: Approved globally for equivalent uses; consult local guidelines.

Disclaimer: This article provides general information about Acebutolol for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare provider, such as a cardiologist or primary care physician, before starting or stopping this drug or making any medical decisions. Improper use of this medication can lead to serious health risks, including severe bradycardia or hypotension.

References

  1. U.S. Food and Drug Administration (FDA). (2023). Sectral (Acebutolol) Prescribing Information.
    • Official FDA documentation detailing the drug’s approved uses, dosage, and safety.
  2. European Medicines Agency (EMA). (2023). Acebutolol Summary of Product Characteristics.
    • EMA’s comprehensive information on the medication’s indications and precautions in Europe.
  3. National Institutes of Health (NIH). (2023). Acebutolol: MedlinePlus Drug Information.
    • NIH resource providing detailed information on the drug’s uses, side effects, and precautions.
  4. World Health Organization (WHO). (2023). WHO Model List of Essential Medicines: Acebutolol.
    • WHO’s inclusion of Acebutolol as an essential medicine for hypertension.
  5. Journal of the American College of Cardiology. (2020). Beta-Blockers in Hypertension and Arrhythmias.
    • Peer-reviewed article on the efficacy of beta-blockers like Acebutolol (note: access may require a subscription).
Previous ArticleAcetazolamide
Next Article Acarbose
Andrew Parker, MD
  • Website

Dr. Andrew Parker is a board-certified internal medicine physician with over 10 years of clinical experience. He earned his medical degree from the University of California, San Francisco (UCSF), and has worked at leading hospitals including St. Mary’s Medical Center. Dr. Parker specializes in patient education and digital health communication. He now focuses on creating clear, accessible, and evidence-based medical content for the public.

Related Posts

Vericiguat

September 14, 2025

Verteporfin

September 14, 2025

Vibegron

September 14, 2025
Don't Miss
Cancer

Squamous Cell Carcinoma

Squamous Cell Carcinoma: Symptoms, Causes, Diagnosis and Treatment Squamous cell carcinoma (SCC) is a type…

Chondrosarcom

Cancer

Angiosarcoma

Cancer

Connective Tissue Cancer

Cancer
Our Picks

Squamous Cell Carcinoma

Cancer

Chondrosarcom

Cancer

Angiosarcoma

Cancer

Connective Tissue Cancer

Cancer
About Us
About Us

GoodMedToday is a global health blog providing trustworthy, reader-friendly information on diseases, medications, healthy living, and medical therapies. We help you make informed health decisions with content based on reputable medical sources.

Contact Us: contact@goodmedtoday.com
Contact: +1-320-0123-451

Our Picks
New Comments

    Type above and press Enter to search. Press Esc to cancel.